AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
20 hedge funds and large institutions have $266M invested in Ambrx Biopharma Inc in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$68.7M | |
2 | +$47M | |
3 | +$37.9M | |
4 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
+$35.8M |
5 |
SCM
Suvretta Capital Management
New York
|
+$22.9M |
Top Sellers
No sellers this quarter